Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Health-related quality of life among people living with HIV/AIDS in Togo: individuals and contextual effects.

Yaya I, Djalogue L, Patassi AA, Landoh DE, Assindo A, Nambiema A, Kolani K, Patchali PM, Bignandi EM, Diallo A, Ekouévi DK, Saka B.

BMC Res Notes. 2019 Mar 15;12(1):140. doi: 10.1186/s13104-019-4171-x.

2.

Risk factors of hepatitis B virus surface antigen carriage and serological profile of HBsAg carriers in Lomé Togo, 2016.

Halatoko WA, Patassi A, Yanogo P, Banla LI, Koba A, Issa Z, Akolly K, Tchalla AM, Assane H, Naba-Mouchedou A, Sawadogo B, Antara SN, Badziklou K, Banla AK, Ekouevi DK, Sanou I.

BMC Public Health. 2019 Jan 8;19(1):32. doi: 10.1186/s12889-018-6320-x.

3.

Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: a cross-sectional study.

Yaya I, Patassi AA, Landoh DE, Bignandi EM, Kolani K, Namoro AD, Patchali PM, Djalogue L, Ekouevi DK, Saka B.

BMJ Open. 2018 Apr 24;8(4):e019006. doi: 10.1136/bmjopen-2017-019006.

4.

Emergence of Lassa Fever Disease in Northern Togo: Report of Two Cases in Oti District in 2016.

Patassi AA, Landoh DE, Mebiny-Essoh Tchalla A, Halatoko WA, Assane H, Saka B, Naba MA, Yaya I, Edou KA, Tamekloe TA, Banla AK, Davi KM, Manga M, Kassankogno Y, Salmon-Ceron D.

Case Rep Infect Dis. 2017;2017:8242313. doi: 10.1155/2017/8242313. Epub 2017 Dec 17.

5.

Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa.

Coffie PA, Egger M, Vinikoor MJ, Zannou M, Diero L, Patassi A, Kuniholm MH, Seydi M, Bado G, Ocama P, Andersson MI, Messou E, Minga A, Easterbrook P, Anastos K, Dabis F, Wandeler G; IeDEA collaboration.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):706. doi: 10.1186/s12879-017-2768-z. Review.

6.

Tuberculosis of the Breast in Togo: A Series of 28 Presumed Cases.

Darré T, Tchaou M, N'Timon B, Patassi AA, Aboubakari A, Sonhaye L, Bassowa A, Amegbor K, Napo-Koura G.

Bull Soc Pathol Exot. 2017 Oct;110(4):238-241. doi: 10.1007/s13149-017-0576-8. Epub 2017 Oct 11.

PMID:
29019164
7.

Changes in viral hepatitis B screening practices over time in West African HIV clinics.

Coffie PA, Patassi A, Doumbia A, Bado G, Messou E, Minga A, Allah-Kouadio E, Zannou DM, Seydi M, Kakou AR, Dabis F, Wandeler G.

Med Mal Infect. 2017 Oct;47(6):394-400. doi: 10.1016/j.medmal.2017.04.011. Epub 2017 May 23.

PMID:
28545675
8.

Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.

Jaquet A, Wandeler G, Nouaman M, Ekouevi DK, Tine J, Patassi A, Coffie PA, Tanon A, Seydi M, Attia A, Dabis F.

J Int AIDS Soc. 2017 Feb 17;19(1):21424. doi: 10.7448/IAS.20.1.21424.

9.

HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa.

Jaquet A, Wandeler G, Tine J, Dagnra CA, Attia A, Patassi A, Ndiaye A, de Ledinghen V, Ekouevi DK, Seydi M, Dabis F.

BMC Infect Dis. 2016 Jun 6;16:249. doi: 10.1186/s12879-016-1601-4.

10.

Hepatitis B infection in HIV-1-infected patients receiving highly active antiretroviral therapy in Lomé, Togo: Prevalence and molecular consequences.

Patassi A, Benaboud S, Landoh DE, Salou M, Dagnra AC, Saka B, Krivine A, Meritet JF, Pitché P, Salmon-Ceron D.

S Afr Med J. 2016 May 10;106(6). doi: 10.7196/SAMJ.2016.v106i6.10312.

PMID:
27245734
11.

Detection and management of the first human anthrax outbreak in Togo.

Patassi AA, Saka B, Landoh DE, Agbenoko K, Tamekloe T, Salmon-Ceron D.

Trop Doct. 2016 Jul;46(3):129-34. doi: 10.1177/0049475515622331. Epub 2015 Dec 14.

PMID:
26672006
12.

[Analysis of a series of 44 cases of peritoneal tuberculosis diagnosed in the pathology laboratory of the Tokoin teaching hospital of Lomé (1993-2014)].

Darré T, Tchaou M, Sonhaye L, Patassi AA, Kanassoua K, Tchangai B, Amegbor K, Napo-Koura G.

Bull Soc Pathol Exot. 2015 Dec;108(5):324-7. doi: 10.1007/s13149-015-0458-x. Epub 2015 Nov 25. French.

PMID:
26608272
13.

HIV status disclosure to sexual partners, among people living with HIV and AIDS on antiretroviral therapy at Sokodé regional hospital, Togo.

Yaya I, Saka B, Landoh DE, Patchali PM, Patassi AA, Aboubakari AS, Makawa MS, N'Dri MK, Senanou S, Lamboni B, Idrissou D, Salaka KT, Pitché P.

PLoS One. 2015 Feb 6;10(2):e0118157. doi: 10.1371/journal.pone.0118157. eCollection 2015.

14.

Predictors of adherence to antiretroviral therapy among people living with HIV and AIDS at the regional hospital of Sokodé, Togo.

Yaya I, Landoh DE, Saka B, Patchali PM, Wasswa P, Aboubakari AS, N'Dri MK, Patassi AA, Kombaté K, Pitche P.

BMC Public Health. 2014 Dec 19;14:1308. doi: 10.1186/1471-2458-14-1308.

15.

Intimate partner sexual and physical violence among women in Togo, West Africa: prevalence, associated factors, and the specific role of HIV infection.

Burgos-Soto J, Orne-Gliemann J, Encrenaz G, Patassi A, Woronowski A, Kariyiare B, Lawson-Evi AK, Leroy V, Dabis F, Ekouevi DK, Becquet R.

Glob Health Action. 2014 May 26;7:23456. doi: 10.3402/gha.v7.23456. eCollection 2014.

16.

Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial.

Klement E, Pitché P, Kendjo E, Singo A, D'Almeida S, Akouete F, Akpaloo Y, Tossa K, Prince-Agbodjan S, Patassi A, Caumes E.

Clin Infect Dis. 2014 Mar;58(5):651-9. doi: 10.1093/cid/cit806. Epub 2013 Dec 12.

PMID:
24336820
17.

First observation in a non-endemic country (Togo) of Penicillium marneffei infection in a human immunodeficiency virus-infected patient: a case report.

Patassi AA, Saka B, Landoh DE, Kotosso A, Mawu K, Halatoko WA, Wateba MI, Adjoh K, Tidjani O, Salmon D, Pitché P.

BMC Res Notes. 2013 Dec 4;6:506. doi: 10.1186/1756-0500-6-506.

18.

National surveillance data on the epidemiology of cholera in Togo.

Landoh DE, Gessner BD, Badziklou K, Tamekloe T, Nassoury DI, Dagnra A, Patassi A, Tante O, Bidjada B, Tigossou S, Banla KA.

J Infect Dis. 2013 Nov 1;208 Suppl 1:S115-9. doi: 10.1093/infdis/jit244. Erratum in: J Infect Dis. 2014 May 1;209(9):1494. Essoya, Landoh Dadja [corrected to Landoh, Dadja Essoya]; Kossi, Badziklou [corrected to Badziklou, Kossi]; Tsidi, Tamekloe [corrected to Tamekloe, Tsidi]; Ibrahim, Nassoury Dalandi [corrected to Nassoury, Danlai Ibrahim]; Anoumou, Dagnra [corrected to Dag.

PMID:
24101639
19.

Loss of HIV-infected patients on potent antiretroviral therapy programs in Togo: risk factors and the fate of these patients.

Saka B, Landoh DE, Patassi A, d'Almeida S, Singo A, Gessner BD, Pitché PV.

Pan Afr Med J. 2013 May 26;15:35. doi: 10.11604/pamj.2013.15.35.2198. eCollection 2013.

20.

Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.

Ekouevi DK, Balestre E, Coffie PA, Minta D, Messou E, Sawadogo A, Minga A, Sow PS, Bissagnene E, Eholie SP, Gottlieb GS, Dabis F; IeDEA West Africa collaboration, Zannou DM, Ahouada C, Akakpo J, Ahomadegbé C, Bashi J, Gougounon-Houéto A, Azon-Kouanou A, Houngbé F, Koumakpaï S, Alihonou F, d'Almeida M, Hodonou I, Hounhoui G, Sagbo G, Tossa-Bagnan L, Adjide H, Drabo J, Bognounou R, Dienderé A, Traore E, Zoungrana L, Zerbo B, Sawadogo AB, Zoungrana J, Héma A, Soré I, Bado G, Tapsoba A, Yé D, Kouéta F, Ouedraogo S, Ouédraogo R, Hiembo W, Gansonré M, Messou E, Gnokoro JC, Koné M, Kouakou GM, Bosse CA, Brou K, Assi AI, Chenal H, Hawerlander D, Soppi F, Minga A, Abo Y, Bomisso G, Eholié SP, Amego MD, Andavi V, Diallo Z, Ello F, Tanon AK, Koule SO, Anzan KC, Guehi C, Aka EA, Issouf KL, Kouakou JC, N'gbeche MS, Touré P, Avit-Edi D, Kouakou K, Moh M, Yao VA, Folquet MA, Dainguy ME, Kouakou C, Méa-Assande VT, Oka-Berete G, Zobo N, Acquah P, Kokora MB, Eboua TF, Timité-Konan M, Ahoussou LD, Assouan JK, Sami MF, Kouadio C, Renner L, Goka B, Welbeck J, Sackey A, Owiafe SN, Wejse C, Silva ZJ, Paulo J, Rodrigues A, da Silva D, Medina C, Oliviera-Souto I, Ostergaard L, Laursen A, Sodemann M, Aaby P, Fomsgaard A, Erikstrup C, Eugen-Olsen J, Maïga MY, Diakité FF, Kalle A, Katile D, Traore HA, Minta D, Cissé T, Dembelé M, Doumbia M, Fomba M, Kaya AS, Traoré AM, Traoré H, Toure AA, Dicko F, Sylla M, Berthé A, Traoré HC, Koïta A, Koné N, N'diaye C, Coulibaly ST, Traoré M, Traoré N, Charurat M, Ajayi S, Dapiap S, Otu, Igbinoba F, Benson O, Adebamowo C, James J, Obaseki, Osakede P, Olasode J, Sow PS, Diop B, Manga NM, Tine JM, Signate Sy H, Ba A, Diagne A, Dior H, Faye M, Gueye RD, Mbaye AD, Patassi A, Kotosso A, Kariyare BG, Gbadamassi G, Komi A, Mensah-Zukong KE, Pakpame P, Lawson-Evi AK, Atakouma Y, Takassi E, Djeha A, Ephoévi-Gah A, Djibril Sel-H, Dabis F, Bissagnene E, Arrivé E, Coffie P, Ekouevi D, Jaquet A, Leroy V, Lewden C, Sasco A, Azani JC, Allou G, Balestre E, Bohossou F, Karcher S, Gonsan JM, Carrou JL, Lenaud S, Nchot C, Malateste K, Yao AR, Siloué B, Clouet G, Djetouan H, Doring A, Kouakou A, Rabourdin E, Rivenc J, Anglaret X, Ba B, Essanin JB, Ciaranello A, Datté S, Desmonde S, Diby JS, Gottlieb GS, Horo AG, Kangah SN, Malvy D, Meless D, Mounkaila-Harouna A, Ndondoki C, Shiboski C, Thiébaut R, Pac-Ci, Abidjan.

PLoS One. 2013 Jun 18;8(6):e66135. doi: 10.1371/journal.pone.0066135. Print 2013.

21.

Criminal prosecution of a male partner for sexual transmission of infectious diseases: the views of educated people living in Togo.

Kpanake L, Patassi A, Mullet E.

Sex Transm Infect. 2013 Jun;89(4):290-4. doi: 10.1136/sextrans-2012-050964.

PMID:
23687130
22.

[Evaluation of antiretroviral treatment in a cohort of 1,620 HIV-infected patients in Togo].

Saka B, Landoh DE, Kombaté K, Mouhari-Toure A, Makawa MS, Patassi A, Djadou KE, Nabroulaba KT, Messan E, Avodagbe LB, Aho K, Singo A, Pitché P.

Med Sante Trop. 2012 Apr-Jun;22(2):193-7. doi: 10.1684/mst.2012.0054. French.

23.

High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo.

Dagnra AY, Vidal N, Mensah A, Patassi A, Aho K, Salou M, Monleau M, Prince-David M, Singo A, Pitche P, Delaporte E, Peeters M.

J Int AIDS Soc. 2011 Jun 10;14:30. doi: 10.1186/1758-2652-14-30.

24.

[Biological profile of adult patients infected with HIV at initiation of antiretroviral therapy in Togo].

Mouhari-Toure A, Patassi A, Nabroulaba KT, Djadou KE, Edou K, Nyametso D, Aho K, Saïbou A, Kombaté M, Kpanla K, Niman KW, Togbossi A, Agodomou E, Wotogbe A, Tadona M, Singo A, Déku K, Pitche P.

Med Mal Infect. 2011 May;41(5):229-34. doi: 10.1016/j.medmal.2010.11.007. Epub 2010 Dec 30. French.

PMID:
21194864
25.

[Kidney ultrasound scan performed on the adult patient with HIV serology positive in the University Hospital of Tokoin and campus of Lome].

Agoda-Koussema LK, Anoukoum T, Patassi AA, Adjenou KV, Awi YG, Awobanou KM, N'dakena KG.

Mali Med. 2011;26(2):21-6. French.

PMID:
22766454
26.

[Prevalence of HIV-TB co-infection and impact of HIV infection on pulmonary tuberculosis outcome in Togo].

Dagnra AY, Adjoh K, Tchaptchet Heunda S, Patassi AA, Sadzo Hetsu D, Awokou F, Tidjani O.

Bull Soc Pathol Exot. 2011 Dec;104(5):342-6. doi: 10.1007/s13149-010-0079-3. Epub 2010 Sep 4. French.

PMID:
20821178
27.

Risk factors for surgical wound infection in HIV-positive patients undergoing surgery for orthopaedic trauma.

Abalo A, Patassi A, James YE, Walla A, Sangare A, Dossim A.

J Orthop Surg (Hong Kong). 2010 Aug;18(2):224-7.

PMID:
20808017
28.

[Tetanus and HIV: a fortuitous association?].

Wateba M, Diop S, Nichols S, Adjoh S, Gbadamassi G, Patassi A, Tidjani O.

Sante. 2008 Jul-Sep;18(3):131-4. doi: 10.1684/san.2008.0114. French.

29.

[Intrathecal therapy with 1 500 UI of antitetanic serum and 1.5 g of intravenous metronidazole: prognosis of tetanus in hospitalized patients in Togo].

Wateba M, Diop S, Nichols S, Patassi A, Adjo S, Gbadamassi G, Tidjani O.

Sante. 2008 Jul-Sep;18(3):125-9. doi: 10.1684/san.2008.0115. French.

Supplemental Content

Loading ...
Support Center